News & Analysis as of

Libor Pfizer

Robins Kaplan LLP

Financial Daily Dose 11.9.2020 | Top Story: Pfizer’s Vaccine News and Election Certainty Propel Wall Street Futures Skyward

Robins Kaplan LLP on

So . . . .  Nice, quiet week while we were gone, right? Wall Street forecasts are always dicey, but it sure looks like Pfizer’s solid vaccine news (along with this weekend’s newfound presidential certainty) could make for...more

Robins Kaplan LLP

Your daily dose of financial news The Brief – 4.6.16

Robins Kaplan LLP on

Talk about a regulation with teeth. Within days of the Treasury Department announcing new rules meant to discourage corporate tax inversion deals, Pfizer and Allergan announced they were scrapping their planned $152 billion...more

Robins Kaplan LLP

Your daily dose of financial news The Brief – 11.24.15

Robins Kaplan LLP on

The Pfizer/Allergan deal continues to dominate the financial world, with Pfizer’s CEO defending the merger and Washington searching for ways to reform the corporate tax code and prevent future tax-motivated corporate...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide